Click on the panels below to find out more about our latest hosted content
A survey of 710 people with rosacea and 554 doctors has revealed valuable insights on the invisible impact of a visible disease for the patients and the community. It is time to fight back against stereotypes and talk openly about rosacea burden.
Hear from Dr Nick Panay(Consultant Gynaecologist and Director of the West London Menopause and PMS Centre) andDr Jane F Wilkinson(NHS GP Chester, British Menopause Society - accredited Menopause Specialist, GP Champion for Sexual Health, Wirral)This page and these videos have been developed and funded by Besins Healthcare (UK) Ltd, are intended for healthcare professionals only and contain promotional content. OES/2022/005 | May 2022
For UK and IE healthcare professionals only. The Iron Deficiency Anaemia Resource is designed for healthcare professionals who manage patients with chronic kidney disease, congestive heart failure, inflammatory bowel disease or those listed for major elective surgery.
Click here for Prescribing Information
Job code: UKIE-MONF-1221-00002Date of preparation: January 2022
Date of preparation: December 2022MAT-IE-2100533(V3.0)
This webpage contains promotional content intended for healthcare professionals only. Click for prescribing information.1. UK/IE VEKLURY® Summary of Product Characteristics. Accessed January 2023.Job code: IHQ-VKY-0269Date of prep: April 2023Developed and funded by Gilead Sciences Ltd.
This webpage contains promotional content intended for healthcare professionals only.
Click for prescribing information.
Job code: IHQ-LEN-0030Date of prep: February 2023Developed and funded by Gilead Sciences Ltd.
This webpage contains educational, promotional content intended for healthcare professionals only.
Click for prescribing information.
Jobe code: IHQ-VKY-0177 Date of preparation: April 2023
Developed and funded by Gilead Sciences Europe Ltd.
HQ-PAT-2200109 Date of preparation: November 2022
This is a non-promotional medical education resource hosted on the BMJ, produced and funded by Alexion, AstraZeneca rare disease, and intended for healthcare professionals.© 2022, Alexion Pharmaceuticals, Inc. All rights reserved. INT/UNB-H/0077 | November 2022